European Journal of Pediatrics

, Volume 171, Issue 5, pp 757–765

Educational paper

Retinal dystrophies and gene therapy
  • Venki Sundaram
  • Anthony T. Moore
  • Robin R. Ali
  • James W. Bainbridge


Retinal dystrophies are inherited disorders of photoreceptor and retinal pigment epithelial function that may result in severe visual impairment. Advances in molecular genetics have helped identify many of the gene defects responsible, and progress in gene transfer technology has enabled therapeutic strategies to be developed and applied. The first human clinical trials of gene therapy for RPE65 associated retinal dystrophy have shown promising initial results and have helped prepare the way for further trials of gene therapy for inherited retinal disorders. The results of these trials will provide further insight into the safety and efficacy of gene therapy for a range of currently untreatable and debilitating eye disorders.


Retinal dystrophy Childhood Gene therapy Viral vector Subretinal 


  1. 1.
    Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K, Hauswirth WW, Jacobson SG (2005) Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 12:1072–1082CrossRefPubMedGoogle Scholar
  2. 2.
    Alexander JJ, Umino Y, Everhart D, Chang B, Min SH, Li Q, Timmers AM, Hawes NL, Pang JJ, Barlow RB, Hauswirth WW (2007) Restoration of cone vision in a mouse model of achromatopsia. Nat Med 13:685–687CrossRefPubMedGoogle Scholar
  3. 3.
    Allen LE, Zito I, Bradshaw K, Patel RJ, Bird AC, Fitzke F, Yates JR, Trump D, Hardcastle AJ, Moore AT (2003) Genotype-phenotype correlation in British families with X linked congenital stationary night blindness. Br J Ophthalmol 87:1413–1420CrossRefPubMedGoogle Scholar
  4. 4.
    Allocca M, Doria M, Petrillo M, Colella P, Garcia-Hoyos M, Gibbs D, Kim SR, Maguire A, Rex TS, Di Vicino U, Cutillo L, Sparrow JR, Williams DS, Bennett J, Auricchio A (2008) Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest 118:1955–1964CrossRefPubMedGoogle Scholar
  5. 5.
    Andreasson S, Tornqvist K (1991) Electroretinograms in patients with achromatopsia. Acta Ophthalmol (Copenh) 69:711–716CrossRefGoogle Scholar
  6. 6.
    Bainbridge JW, Mistry A, Schlichtenbrede FC, Smith A, Broderick C, De Alwis M, Georgiadis A, Taylor PM, Squires M, Sethi C, Charteris D, Thrasher AJ, Sargan D, Ali RR (2003) Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina. Gene Ther 10:1336–1344CrossRefPubMedGoogle Scholar
  7. 7.
    Bainbridge JWB, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, Petersen-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS, Moore AT, Ali RR (2008) Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med 358:2231–2239CrossRefPubMedGoogle Scholar
  8. 8.
    Bech-Hansen NT, Naylor MJ, Maybaum TA, Pearce WG, Koop B, Fishman GA, Mets M, Musarella MA, Boycott KM (1998) Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet 19:264–267CrossRefPubMedGoogle Scholar
  9. 9.
    Bech-Hansen NT, Naylor MJ, Maybaum TA, Sparkes RL, Koop B, Birch DG, Bergen AA, Prinsen CF, Polomeno RC, Gal A, Drack AV, Musarella MA, Jacobson SG, Young RS, Weleber RG (2000) Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet 26:319–323CrossRefPubMedGoogle Scholar
  10. 10.
    Berger W, Kloeckener-Gruissem B, Neidhardt J (2010) The molecular basis of human retinal and vitreoretinal diseases. Prog Retin Eye Res 29:335–375CrossRefPubMedGoogle Scholar
  11. 11.
    Burgess R, Millar ID, Leroy BP, Urquhart JE, Fearon IM, De Baere E, Brown PD, Robson AG, Wright GA, Kestelyn P, Holder GE, Webster AR, Manson FD, Black GC (2008) Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet 82:19–31CrossRefPubMedGoogle Scholar
  12. 12.
    Conley SM, Cai X, Naash MI (2008) Nonviral ocular gene therapy: assessment and future directions. Curr Opin Mol Ther 10:456–463PubMedGoogle Scholar
  13. 13.
    Dejneka NS, Surace EM, Aleman TS, Cideciyan AV, Lyubarsky A, Savchenko A, Redmond TM, Tang W, Wei Z, Rex TS, Glover E, Maguire AM, Pugh EN Jr, Jacobson SG, Bennett J (2004) In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther 9:182–188CrossRefPubMedGoogle Scholar
  14. 14.
    Denhollander A, Roepman R, Koenekoop R, Cremers F (2008) Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retinal Eye Res 27:391–419CrossRefGoogle Scholar
  15. 15.
    Deutman AF (1969) Electro-oculography in families with vitelliform dystrophy of the fovea. Detection of the carrier state. Arch Ophthalmol 81:305–316CrossRefPubMedGoogle Scholar
  16. 16.
    Gregori NZ, Berrocal AM, Gregori G, Murray TG, Knighton RW, Flynn HW Jr, Dubovy S, Puliafito CA, Rosenfeld PJ (2009) Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis. Br J Ophthalmol 93:373–378CrossRefPubMedGoogle Scholar
  17. 17.
    Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ, Jacobson SG (2008) Treatment of Leber congenital amaurosis due toRPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Human Gene Ther 19:979–990CrossRefGoogle Scholar
  18. 18.
    Jacobson SG, Cideciyan AV, Aleman T, Sumaroka A, Roman AJ, Swider M, Schwartz SB, Banin E, Stone EM (2011) Human retinal disease from AIPL1 gene mutations: foveal cone loss with minimal macular photoreceptors and rod function remaining. Invest Ophthalmol Vis Sci 52(1):70–79CrossRefPubMedGoogle Scholar
  19. 19.
    Johnson S, Michaelides M, Aligianis IA, Ainsworth JR, Mollon JD, Maher ER, Moore AT, Hunt DM (2004) Achromatopsia caused by novel mutations in both CNGA3 and CNGB3. J Med Genet 41:e20CrossRefPubMedGoogle Scholar
  20. 20.
    Kohl S, Baumann B, Rosenberg T, Kellner U, Lorenz B, Vadala M, Jacobson SG, Wissinger B (2002) Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia. Am J Hum Genet 71:422–425CrossRefPubMedGoogle Scholar
  21. 21.
    Komaromy AM, Alexander JJ, Rowlan JS, Garcia MM, Chiodo VA, Kaya A, Tanaka JC, Acland GM, Hauswirth WW, Aguirre GD (2010) Gene therapy rescues cone function in congenital achromatopsia. Hum Mol Genet 19:2581–2593CrossRefPubMedGoogle Scholar
  22. 22.
    Kong J, Kim SR, Binley K, Pata I, Doi K, Mannik J, Zernant-Rajang J, Kan O, Iqball S, Naylor S, Sparrow JR, Gouras P, Allikmets R (2008) Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy. Gene Ther 15:1311–1320CrossRefPubMedGoogle Scholar
  23. 23.
    Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S et al (2008) Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med 358:2240–2248CrossRefPubMedGoogle Scholar
  24. 24.
    Maguire AM, High KA, Auricchio A, Wright JF, Pierce EA, Testa F, Mingozzi F, Bennicelli JL, G-s Y, Rossi S (2009) Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: a phase 1 dose-escalation trial. Lancet 374:1597–1605CrossRefPubMedGoogle Scholar
  25. 25.
    Maugeri A, Klevering BJ, Rohrschneider K, Blankenagel A, Brunner HG, Deutman AF, Hoyng CB, Cremers FP (2000) Mutations in the ABCA4 (ABCR) gene are the major cause of autosomal recessive cone-rod dystrophy. Am J Hum Genet 67:960–966CrossRefPubMedGoogle Scholar
  26. 26.
    Michaelides M, Hunt DM, Moore AT (2004) The cone dysfunction syndromes. Br J Ophthalmol 88:291–297CrossRefPubMedGoogle Scholar
  27. 27.
    Michaelides M, Hardcastle AJ, Hunt DM, Moore AT (2006) Progressive cone and cone-rod dystrophies: phenotypes and underlying molecular genetic basis. Surv Ophthalmol 51:232–258CrossRefPubMedGoogle Scholar
  28. 28.
    Michalakis S, Muhlfriedel R, Tanimoto N, Krishnamoorthy V, Koch S, Fischer MD, Becirovic E, Bai L, Huber G, Beck SC, Fahl E, Buning H, Paquet-Durand F, Zong X, Gollisch T, Biel M, Seeliger MW (2010) Restoration of cone vision in the CNGA3−/− mouse model of congenital complete lack of cone photoreceptor function. Mol Ther 18:2057–2063CrossRefPubMedGoogle Scholar
  29. 29.
    Min SH, Molday LL, Seeliger MW, Dinculescu A, Timmers AM, Janssen A, Tonagel F, Tanimoto N, Weber BH, Molday RS, Hauswirth WW (2005) Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis. Mol Ther 12:644–651CrossRefPubMedGoogle Scholar
  30. 30.
    Park TK, Wu Z, Kjellstrom S, Zeng Y, Bush RA, Sieving PA, Colosi P (2009) Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse. Gene Ther 16:916–926CrossRefPubMedGoogle Scholar
  31. 31.
    Pauwels K, Gijsbers R, Toelen J, Schambach A, Willard-Gallo K, Verheust C, Debyser Z, Herman P (2009) State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations. Curr Gene Ther 9:459–474CrossRefPubMedGoogle Scholar
  32. 32.
    Petrukhin K, Koisti MJ, Bakall B, Li W, Xie G, Marknell T, Sandgren O, Forsman K, Holmgren G, Andreasson S, Vujic M, Bergen AA, McGarty-Dugan V, Figueroa D, Austin CP, Metzker ML, Caskey CT, Wadelius C (1998) Identification of the gene responsible for Best macular dystrophy. Nat Genet 19:241–247CrossRefPubMedGoogle Scholar
  33. 33.
    Querques G, Zerbib J, Santacroce R, Margaglione M, Delphin N, Rozet JM, Kaplan J, Martinelli D, Delle Noci N, Soubrane G, Souied EH (2009) Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene. Mol Vis 15:2960–2972PubMedGoogle Scholar
  34. 34.
    Reichel MB, Ali RR, Thrasher AJ, Hunt DM, Bhattacharya SS, Baker D (1998) Immune responses limit adenovirally mediated gene expression in the adult mouse eye. Gene Ther 5:1038–1046CrossRefPubMedGoogle Scholar
  35. 35.
    Rolling F (2004) Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives. Gene Ther 11(Suppl 1):S26–32CrossRefPubMedGoogle Scholar
  36. 36.
    Sikkink SK, Biswas S, Parry NR, Stanga PE, Trump D (2007) X-linked retinoschisis: an update. J Med Genet 44:225–232CrossRefPubMedGoogle Scholar
  37. 37.
    Simonelli F, Maguire AM, Testa F, Pierce EA, Mingozzi F, Bennicelli JL, Rossi S, Marshall K, Banfi S, Surace EM, Sun J, Redmond TM, Zhu X, Shindler KS, Ying G-S, Ziviello C, Acerra C, Wright JF, McDonnell JW, High KA, Bennett J, Auricchio A (2009) Gene therapy for Leber’s congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 18:643–650CrossRefPubMedGoogle Scholar
  38. 38.
    Smith AJ, Bainbridge JW, Ali RR (2009) Prospects for retinal gene replacement therapy. Trends Genet 25:156–165CrossRefPubMedGoogle Scholar
  39. 39.
    Sun H, Tsunenari T, Yau KW, Nathans J (2002) The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A 99:4008–4013CrossRefPubMedGoogle Scholar
  40. 40.
    Thiadens AA, den Hollander AI, Roosing S, Nabuurs SB, Zekveld-Vroon RC, Collin RW, De Baere E, Koenekoop RK, van Schooneveld MJ, Strom TM, van Lith-Verhoeven JJ, Lotery AJ, van Moll-Ramirez N, Leroy BP, van den Born LI, Hoyng CB, Cremers FP, Klaver CC (2009) Homozygosity mapping reveals PDE6C mutations in patients with early-onset cone photoreceptor disorders. Am J Hum Genet 85:240–247CrossRefPubMedGoogle Scholar
  41. 41.
    Thiadens AA, Somervuo V, van den Born LI, Roosing S, van Schooneveld MJ, Kuijpers RW, van Moll-Ramirez N, Cremers FP, Hoyng CB, Klaver CC (2010) Progressive loss of cones in achromatopsia: an imaging study using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 51:5952–5957CrossRefPubMedGoogle Scholar
  42. 42.
    Thomas MG, Kumar A, Kohl S, Proudlock FA, Gottlob I (2011) High-resolution in vivo imaging in achromatopsia. Ophthalmol 118:882–887CrossRefGoogle Scholar
  43. 43.
    Vervoort R, Lennon A, Bird AC, Tulloch B, Axton R, Miano MG, Meindl A, Meitinger T, Ciccodicola A, Wright AF (2000) Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet 25:462–466CrossRefPubMedGoogle Scholar
  44. 44.
    Walia S, Fishman GA (2009) Natural history of phenotypic changes in Stargardt macular dystrophy. Ophthalmic Genet 30:63–68CrossRefPubMedGoogle Scholar
  45. 45.
    Weber M, Rabinowitz J, Provost N, Conrath H, Folliot S, Briot D, Cherel Y, Chenuaud P, Samulski J, Moullier P, Rolling F (2003) Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. Mol Ther 7:774–781CrossRefPubMedGoogle Scholar
  46. 46.
    Weingeist TA, Kobrin JL, Watzke RC (1982) Histopathology of Best’s macular dystrophy. Arch Ophthalmol 100:1108–1114CrossRefPubMedGoogle Scholar
  47. 47.
    West EL, Pearson RA, MacLaren RE, Sowden JC, Ali RR (2009) Cell transplantation strategies for retinal repair. Prog Brain Res 175:3–21CrossRefPubMedGoogle Scholar
  48. 48.
    Winter JO, Cogan SF, Rizzo JF 3rd (2007) Retinal prostheses: current challenges and future outlook. J Biomater Sci Polym Ed 18:1031–1055CrossRefPubMedGoogle Scholar
  49. 49.
    Yanez-Munoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, Smith AJ, Buch P, MacLaren RE, Anderson PN, Barker SE, Duran Y, Bartholomae C, von Kalle C, Heckenlively JR, Kinnon C, Ali RR, Thrasher AJ (2006) Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12:348–353CrossRefPubMedGoogle Scholar
  50. 50.
    Zeng Y, Takada Y, Kjellstrom S, Hiriyanna K, Tanikawa A, Wawrousek E, Smaoui N, Caruso R, Bush RA, Sieving PA (2004) RS-1 gene delivery to an adult Rs1h knockout mouse model restores ERG b-wave with reversal of the electronegative waveform of X-linked retinoschisis. Invest Ophthalmol Vis Sci 45:3279–3285CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Venki Sundaram
    • 1
    • 2
  • Anthony T. Moore
    • 1
    • 2
  • Robin R. Ali
    • 1
  • James W. Bainbridge
    • 1
    • 2
  1. 1.Institute of OphthalmologyUniversity College LondonLondonUK
  2. 2.Moorfields Eye HospitalNHS Foundation TrustLondonUK

Personalised recommendations